Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New combo approach aims to stop pancreatitis after stone treatment

NCT ID NCT07202559

First seen Nov 01, 2025 · Last updated Jun 20, 2026 · Updated 36 times

Summary

This study tests whether giving extra IV fluids along with a standard anti-inflammatory suppository can better prevent pancreatitis after a procedure to break up pancreatic stones. About 1250 adults with chronic pancreatitis will be randomly assigned to receive either the combination or the suppository alone. The main goal is to see if the combination reduces the number of people who develop pancreatitis after the procedure.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATITIS, CHRONIC are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Changhai Hospital

    RECRUITING

    Shanghai, China

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

  • Hangzhou First People's Hospital

    RECRUITING

    Hangzhou, China

    Contact

  • Peking Union Medical College Hospital

    RECRUITING

    Beijing, China

    Contact

  • Qilu Hospital of Shandong University

    RECRUITING

    Shandong, China

    Contact

  • Ruijin Hospital

    RECRUITING

    Shanghai, China

    Contact Phone: •••-•••-••••

  • Shanghai Pudong New Area Gongli Hospital

    RECRUITING

    Shanghai, China

    Contact

  • The First Hospital of Lanzhou University

    NOT_YET_RECRUITING

    Lanzhou, China

    Contact Phone: •••-•••-••••

  • The Second Affiliated Hospital of Baotou Medical College

    RECRUITING

    Baotou, China

    Contact Phone: •••-•••-••••

  • The Third Xiangya Hospital of Central South University

    RECRUITING

    Hunan, China

    Contact Phone: •••-•••-••••

  • Yunnan University Affiliated Hospital

    NOT_YET_RECRUITING

    Yunnan, China

    Contact Phone: •••-•••-••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Lactated Ringer's solution and indometacin suppository

What this could lead to

If it works, this could become a standard way to prevent pancreatitis after pancreatic stone treatment, reducing serious complications.

What could go wrong

This is an early-stage trial without a phase designation, so results are uncertain. Adding IV fluids may not improve outcomes and could cause fluid overload in some patients.

Conditions

The condition(s) this trial relates to.

chronic pancreatitis pancreatitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.